GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to ease myasthenia gravis symptoms
Disease control Recruiting nowThis study is testing two drugs, efgartigimod and empasiprubart, given by IV, to see if they are safe and work well for people with myasthenia gravis (MG). The goal is to reduce side effects and improve quality of life. About 70 adults with MG are being recruited.
Matched conditions: GMG
Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New drug combo aims to ease muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests whether adding empasiprubart to the existing drug efgartigimod can improve symptoms and daily function in people with generalized myasthenia gravis who still have symptoms on efgartigimod alone. About 70 participants will receive both drugs intravenously. The mai…
Matched conditions: GMG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Real-World study tracks Efgartigimod's impact on myasthenia gravis symptoms
Disease control Recruiting nowThis study follows 100 adults in Italy with generalized myasthenia gravis who are starting efgartigimod as part of their routine care. Researchers will track changes in symptoms and daily activities over up to 23 months using patient reports and doctor assessments. The goal is to…
Matched conditions: GMG
Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a new drug help myasthenia gravis patients ditch steroids?
Disease control Recruiting nowThis study is testing whether the drug ravulizumab can help people with generalized myasthenia gravis (gMG) safely reduce or stop taking oral steroids. About 75 adults who are already on ravulizumab and taking at least 7.5 mg of prednisone daily will follow a gradual steroid-tape…
Matched conditions: GMG
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control Recruiting nowThis study tests a drug called gefurulimab in 12 children aged 6 to 18 with generalized myasthenia gravis, a condition that causes muscle weakness. The drug works by blocking a part of the immune system to reduce symptoms. Participants receive weekly injections, and researchers w…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC